TABLE 2.
Inappropriate Antidepressants (N = 579) | |
Amitriptyline | 104 (17.96) |
Clomipramine | 2 (0.35) |
Desipramine | 3 (0.52) |
Doxepin | 32 (5.53) |
Imipramine | 9 (1.55) |
Nortriptyline | 35 (6.04) |
Paroxetine | 394 (68.05) |
Appropriate Antidepressants (N = 7,046) | |
Bupropion | 194 (2.75) |
Citalopram | 1,552 (22.03) |
Desvenlafaxine | 32 (0.45) |
Duloxetine | 475 (6.74) |
Escitalopram | 1,055 (14.97) |
Fluoxetine | 361 (5.12) |
Fluoxetine/olanzapine | 1 (0.01) |
Fluvoxamine | 7 (0.10) |
Mirtazapine | 1,042 (14.79) |
Nefazodone | 2 (0.03) |
Phenelzine | 0 (0.00) |
Selegiline | 3 (0.04) |
Sertraline | 1,543 (21.90) |
Tranylcypromine | 0 (0.00) |
Trazodone | 489 (6.94) |
Venlafaxine | 265 (3.76) |
Vilazodone | 25 (0.35) |
Notes: Analysis based on 7,625 older adults with dementia and newly diagnosed major depression. At least one potentially inappropriate antidepressant was initiated by 579 (7.59%) older adults in this study sample.